The National Cancer Institute's Office of Cancer Genomics (OCG) aims to advance the understanding of cancer at the molecular level with the ultimate goal of improving clinical outcomes. Through its various innovative and collaborative research programs, OCG fosters cancer genomics research (the systematic analysis of changes in the genomes of tumors) and the rapid translation of the resulting molecular insights into the clinic. Read more about OCG
Publications and data generated from OCG programs, as well as, other cancer-genomics-related resources are made publicly available on this website.
Sign up to receive updates from OCG, including the e-Newsletter.
Latest issue of the OCG e-News!
An update on the CTD² program, an interview with TARGET researcher Kathryn Roberts, and more.
Read the OCG e-News.
Genome Study Points to Treatments for High-Risk Form of Childhood Leukemia
NCI Cancer Bulletin features recently published findings from TARGET researchers studying high-risk acute lymphoblastic leukemia.
Read the Bulletin article.
The genetic landscape of high-risk neuroblastoma
January 20, 2013
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
December 21, 2012
The molecular genetic makeup of acute lymphoblastic leukemia
December 8, 2012
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from The Children's Oncology Group TARGET Project
December 4, 2012
Cancer Vulnerabilities Unveiled by Genomic Loss
August 17, 2012